Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

CSIPI and Shanghai Zhongze Therapeutics patent dopamine D2/D3/5-HT2A receptor antagonists

Dec. 24, 2021

Dual PI3K/BRD4 inhibitors divulged by Monash University, Peter MacCallum Cancer Centre

Dec. 24, 2021

Yumanity Therapeutics discloses PIKfyve inhibitors

Dec. 23, 2021

KSQ Therapeutics synthesizes USP1 inhibitors

Dec. 23, 2021

Gilead Sciences identifies new LPAR1 antagonists

Dec. 23, 2021

Autobahn Therapeutics divulges new thyromimetic compounds

Dec. 23, 2021

Topspin Therapeutics patents TMPRSS2 inhibitors

Dec. 23, 2021

New dihydroorotate dehydrogenase inhibitors described by Medshine Discovery

Dec. 22, 2021

Nanjing Chia Tai Tianqing Pharmaceutical divulges AXL inhibitors

Dec. 22, 2021

Esteve patents dual CACNA2D1/SIGMAR1 ligands

Dec. 22, 2021

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...